BSE filing, NSE: UNICHEMLAB. Summary written from the filing by ALFA Finder's alert engine.
Unichem Laboratories Ltd: key numbers
- Share price
- ₹490.00
- Market cap
- ₹3,450 Cr
- Revenue (annual)
- ₹2,202 Cr
- Net profit (annual)
- ₹252.8 Cr
- P/E (TTM)
- 11.3×Sector 46.5×
- Promoter holding
- 70.22%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unichem Laboratories Ltd
All →Unichem Laboratories Other Announcement
Unichem Laboratories Limited submitted the quarterly compliance certificate under SEBI Regulation 74(5) as provided by its Registrar and Share Transfer Agent.
Unichem Laboratories Business Update
Unichem Laboratories received five procedural observations from the USFDA following an inspection of its Goa formulation facility. The company plans to respond within 15 days.
Unichem Laboratories Legal & Regulatory
Unichem Laboratories received a tax order from the Commissioner (Appeals, Thane) for a penalty and interest liability totaling ₹93.66 Crore. The company intends to file an appeal.
- Value
- ₹93.66 Cr
Unichem Laboratories Employee Stock Options
Unichem extended the exercise period for 3.75 lakh vested ESOP options from 30-Sep-2026 to 31-Mar-2027. The NRC approved the extension via circular resolution under the 2018 Scheme.
Unichem Laboratories Price Movement Clarification
Unichem Laboratories clarified that the recent spurt in trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information to report.
Unichem Laboratories Annual General Meeting
Unichem Laboratories held its 63rd Annual General Meeting on August 11, 2026. The meeting covered the adoption of financial statements and re-appointments of key management personnel.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.